期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Factors of Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Therapy among HIV-TB Co-Infected Individuals in the East Region, Cameroon in the COVID-19 Era: A Retrospective Cohort Study
1
作者 François Anicet Onana Akoa Ulrich Dama +5 位作者 Jean Ndibi Abanda Alphonse Tedonge Asobochia Melkior Fobasso Dzeuta Pearl Nsom Mbu Yokyu Zachary Pangwoh Pierre Yassa Yoniene 《Health》 2024年第2期131-147,共17页
Context/Objectives: Tuberculosis (TB) and HIV co-infection is a serious health problem in Cameroon. The problems associated with poor adherence to treatment are on the increase worldwide. This problem can be observed ... Context/Objectives: Tuberculosis (TB) and HIV co-infection is a serious health problem in Cameroon. The problems associated with poor adherence to treatment are on the increase worldwide. This problem can be observed in all situations where patients are required to administer their own medication, whatever the type of illness. The general objective of this study was to assess the factors affecting adherence to treatment among HIV-TB co-infected patients in health facilities in the East Region in the COVID context. Method: A retrospective cohort study before and during COVID-19 was conducted in HIV care units in 13 health districts in the East Region of Cameroon. Data were collected using a questionnaire recorded in the Kobo Collect android application, analyzed using SPSS version 25 software and plotted using Excel. Results: The pre-COVID-19 cohort compared to the during-COVID-19 cohort had a 1.90 risk of not adhering to treatment (OR: 1.90, CI {1.90 - 3.37}) and the difference was statistically significant at the 5% level (p-value = 0.029). Frequency of adherence was 65.4% (140/214). Adherence before COVID-19 was 56.9% whereas during COVID-19, it was 74.3%. Conclusion: The implementation of targeted interventions in the COVID-19 context, using evidence-based data and integrating the individual needs of HIV-TB co-infected patients, improved adherence to concurrent anti-tuberculosis treatment and antiretroviral therapy during the COVID-19 Era. 展开更多
关键词 factors of adherence Tuberculosis Treatment Antiretroviral Therapy HIV-TB Co-Infection East Region Cameroon
下载PDF
悬浮法与贴壁法提取脂肪组织分泌促成脂因子比较 被引量:1
2
作者 赵学勇 张岩 +1 位作者 于湄 田卫东 《四川大学学报(医学版)》 CAS CSCD 北大核心 2015年第5期773-776,共4页
目的 优化体外获取脂肪组织浸提液的提取方法,比较不同方法提取浸提液的成脂作用。方法 通过贴壁法和悬浮法培养脂肪组织获得浸提液,过滤、冷冻超离心浓缩浸提液,通过BCA试剂盒检测两种方式得到的浸提液分泌因子(secretory factors fro... 目的 优化体外获取脂肪组织浸提液的提取方法,比较不同方法提取浸提液的成脂作用。方法 通过贴壁法和悬浮法培养脂肪组织获得浸提液,过滤、冷冻超离心浓缩浸提液,通过BCA试剂盒检测两种方式得到的浸提液分泌因子(secretory factors from adipose tissue explants,SFAE)蛋白总量及蛋白因子得率。等量蛋白成脂诱导第3代(P3)脂肪干细胞,诱导第7~13d,显微镜下观察及进行油红染色,鉴定成脂情况。结果 贴壁法和悬浮法4次提取浸提液中蛋白含量的差异无统计学意义。但悬浮培养法4次重复实验蛋白因子得率更为稳定,贴壁法每次蛋白因子得率数据相差很大,每克脂肪组织获得分泌蛋白的量最小时为7.3mg,最大可得到12.4mg,而悬浮得到的蛋白因子几乎都趋近于8.7mg。并且贴壁培养法与悬浮培养法相比,获取等量的SFAE需要T75培养瓶更多(10个),且需手工铺匀,贴壁后才能加入培养基,而悬浮培养法仅需悬浮培养瓶1个,加入脂肪组织后即可进行培养。两种方法得到的浸提液都具有促成脂效果,在等量蛋白诱导下的成脂效果差异无统计学意义。结论悬浮和贴壁培养法得到的浸提液具有相同的促成脂能力,但是悬浮培养获得的浸提液更加省时省力且蛋白因子得率稳定,为后续研究和鉴定在SFAE中准确找到成脂因子奠定基础。 展开更多
关键词 脂肪组织 成脂因子 贴壁培养 悬浮培养
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部